SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Cempra, Inc. (CEMP)

CEMP RSS Feed
Add CEMP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/19/2017 3:21:11 PM - Followers: 32 - Board type: Free - Posts Today: 1


http://www.cempra.com/

http://finance.yahoo.com/q/ks?s=CEMP+Key+Statistics


Cempra, Inc., a clinical-stage biopharmaceutical company, engages in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, and skin and skin structure infections. The company's antibiotic candidates in clinical trials stage include Solithromycin, an oral and intravenous fluoroketolide for the treatment of community-acquired bacterial pneumonia; and TAKSTA, a fusidic acid that is active against gram-positive pathogens, including hospital and community-acquired methicillin-resistant S. aureus. Its preclinical programs focus on the discovery, development, and commercialization of macrolides; non-antibacterial preclinical candidates; and research on non-antibacterial candidates. The company was formerly known as Cempra Holdings, LLC and changed its name to Cempra, Inc. in February 2012. Cempra, Inc. was founded in 2005 and is headquartered in Chapel Hill, North Carolina.

 
SureTrader
Interactive Brokers Advertisement
CEMP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CEMP News: Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne 10/10/2017 08:00:00 AM
CEMP News: Proxy Statement - Merger or Acquistion (definitive) (defm14a) 10/05/2017 06:11:44 AM
CEMP News: Melinta Therapeutics Presents Outcomes of Baxdela Treatment of Gram-Positive and Gram-Negative Pathogens at IDWeek 10/04/2017 01:14:15 PM
CEMP News: Current Report Filing (8-k) 09/28/2017 04:30:50 PM
CEMP News: Additional Proxy Soliciting Materials (definitive) (defa14a) 09/28/2017 04:29:06 PM
PostSubject
#427   Why isn’t the company having a call explaining Johnny_C 10/19/17 03:21:11 PM
#426   Cemp meeting November 3 Johnny_C 10/05/17 08:38:38 AM
#425   why all the selling? kayoboi 09/28/17 12:01:46 PM
#424   Something's must have been disclosed at last nights conference Johnny_C 09/27/17 10:04:22 AM
#423   Big difference between the market underpricing a merger Johnny_C 09/23/17 09:52:28 PM
#422   Back from vacation and this pig is still Johnny_C 09/23/17 10:11:17 AM
#421   "..Looks like Morgan Stanley, who put this deal shub 09/18/17 01:53:11 PM
#420   "That firm is a class action firm." agamemnus 09/13/17 09:09:05 PM
#419   "50 is not enough, the bigger point is agamemnus 09/13/17 09:05:36 PM
#418   Looks like Morgan Stanley, who put this deal Johnny_C 09/13/17 05:42:14 PM
#417   50 is not enough, the bigger point is Johnny_C 09/12/17 10:10:04 PM
#416   there will be lawsuits, guaranteed. As far Johnny_C 09/12/17 10:04:34 PM
#415   there will be lawsuits, guaranteed. As far Johnny_C 09/12/17 10:04:34 PM
#414   The fact is that BP messes up rollouts agamemnus 09/12/17 06:34:32 PM
#413   What lawsuits? You mean this one: http://www.prnewswire.com/news-releases/shareholder-alert-montever agamemnus 09/12/17 06:24:56 PM
#412   I keep saying that the market isn't pricing agamemnus 09/12/17 06:22:18 PM
#411   Looks that way to me too Johnny. shub 09/12/17 02:55:26 PM
#410   Here comes the lawsuits... It begins. Johnny_C 09/12/17 01:08:47 PM
#409   It is never a smart strategy for a Johnny_C 09/12/17 07:58:41 AM
#408   Absence of evidence isn't evidence of absence, but agamemnus 09/11/17 03:12:06 PM
#407   50 is probably a little light but 70 Johnny_C 09/11/17 01:31:23 PM
#406   They have stated they want non-dilutive funding from agamemnus 09/11/17 01:02:42 PM
#405   From the slide deck from MS Johnny_C 09/11/17 11:27:03 AM
#404   basically they are saying they are getting hoping Johnny_C 09/11/17 09:33:53 AM
#403   AG - Cemp slide deck for MS out. Johnny_C 09/11/17 09:05:50 AM
#402   I know you are long and most likely Johnny_C 09/11/17 07:42:24 AM
#401   To answer your questions/complaints: agamemnus 09/09/17 05:31:39 PM
#400   They are not that big in the US. Johnny_C 09/09/17 12:27:19 PM
#399   That is true, but if Soli is so Johnny_C 09/08/17 07:31:55 PM
#398   And why would Cemp pay this company 8 Johnny_C 09/08/17 10:16:23 AM
#397   Have you read the 800 plus pages of Johnny_C 09/08/17 08:22:16 AM
#396   Like I said, Sarepta had a good plan. agamemnus 09/07/17 07:12:40 PM
#395   Both companies have large amounts of accumulated deficit... agamemnus 09/07/17 07:10:55 PM
#394   As Ken said, Menarini is a big pharma. agamemnus 09/07/17 07:08:07 PM
#393   Why didn't these losers push back on FDA Johnny_C 09/07/17 10:34:20 AM
#392   All they bring is debt and an approved Johnny_C 09/07/17 09:20:13 AM
#391   Did you read proxie. Cemp management should Johnny_C 09/07/17 09:16:51 AM
#390   No. The currently active lawsuit is a bunch agamemnus 09/05/17 04:19:16 PM
#389   Isn't that one of the reasons they are Johnny_C 09/05/17 04:12:52 PM
#388   But in August? They did not even mention agamemnus 09/05/17 03:29:04 PM
#387   Actually we were very pissed about the manufacturing Johnny_C 09/05/17 01:32:15 PM
#386   Prabha is a scientist. agamemnus 09/05/17 10:52:23 AM
#385   I am not so sure of that 100 Johnny_C 09/02/17 12:05:15 PM
#384   I guess what I don't understand is that, RUMe2 09/01/17 03:28:23 PM
#383   Cemp has about 3.25 in cash and another Johnny_C 09/01/17 01:15:01 PM
#382   I thought 100% this would be approved, my Johnny_C 09/01/17 11:46:47 AM
#381   I did not realize just how poorly run agamemnus 09/01/17 05:37:51 AM
#380   I am buying more but think management are Johnny_C 08/31/17 07:16:15 PM
#379   I bet the chief dish washer knows a agamemnus 08/31/17 01:51:58 AM
#378   Yes, have you talked to chief dish washer Johnny_C 08/30/17 03:12:07 PM
PostSubject